SMALL CELL LUNG CANCER (SCLC)
Clinical trials for SMALL CELL LUNG CANCER (SCLC) explained in plain language.
Never miss a new study
Get alerted when new SMALL CELL LUNG CANCER (SCLC) trials appear
Sign up with your email to follow new studies for SMALL CELL LUNG CANCER (SCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for advanced cancers: drug shows promise in shrinking tumors
Disease control OngoingThis study tests a drug called pembrolizumab in about 1,600 people with advanced solid tumors (like anal, bile duct, or endometrial cancer) that have stopped responding to standard treatments. The goal is to see if the drug can shrink or control the tumors. Participants receive p…
Matched conditions: SMALL CELL LUNG CANCER (SCLC)
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 01, 2026 15:56 UTC
-
Targeted radiation zaps tough lung cancers in early trial
Disease control OngoingThis early-phase study tests a new drug (225Ac-ABD147) that delivers radiation directly to cancer cells in people with small cell lung cancer or large cell neuroendocrine lung cancer whose cancer has grown after platinum chemotherapy. The main goals are to check safety, find the …
Matched conditions: SMALL CELL LUNG CANCER (SCLC)
Phase: PHASE1 • Sponsor: Abdera Therapeutics Inc. • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
New hope for tough lung cancer: tarlatamab takes on relapsed SCLC
Disease control OngoingThis phase 3 study compares a new drug, tarlatamab, with standard treatments for people whose small cell lung cancer has returned after initial chemotherapy. The main goal is to see if tarlatamab helps patients live longer. About 509 adults with measurable disease are participati…
Matched conditions: SMALL CELL LUNG CANCER (SCLC)
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC
-
Can stronger muscles help lung cancer patients beat treatment?
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 160 adults with lung cancer to see if muscle mass, strength, and function are linked to how well they tolerate treatment and their overall survival. Researchers also want to understand why some patients struggle to complete their therapy. The goal is to use the…
Matched conditions: SMALL CELL LUNG CANCER (SCLC)
Sponsor: Zealand University Hospital • Aim: Knowledge-focused
Last updated May 01, 2026 16:00 UTC